Literature DB >> 18705765

Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus.

Yasuka Miyakuni1, Toshiharu Matsumoto, Atsushi Arakawa, Hiroshi Sonoue, Chikako Suzuki, Satoru Takeda.   

Abstract

In endometrioid adenocarcinoma of the uterine corpus, nodal metastasis is related to prognosis. D2-40 immunostaining has recently been used to detect lymphatic invasion, but a study of D2-40 immunostaining for endometrioid adenocarcinoma of the uterine corpus has not been published. Therefore, as a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus, the detection of lymphatic invasion on D2-40 immunostaining and lymphovascular invasion on HE stain was compared. A total of 104 cases of invasive endometrioid adenocarcinoma of the uterine corpus, in which the tumor was located in the uterus, were examined on immunohistochemistry using D2-40. In 20 cases there was lymphatic invasion according to D2-40 immunostaining, and the lymphatic invasion was well detected on D2-40 immunostaining. Nodal metastasis was present in 11 cases. Both lymphatic invasion on D2-40 immunostaining and lymphovascular invasion on HE stain were statistically correlated with nodal metastasis, but the evaluation of lymphatic invasion on D2-40 immunostaining was more accurate than detection of lymphovascular invasion using HE stain, in the current and previous studies, for the prediction of nodal metastasis. In conclusion, lymphatic invasion demonstrated on D2-40 immunostaining is very useful as a predictor for nodal metastasis in endometrioid adenocarcinoma of uterine corpus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705765     DOI: 10.1111/j.1440-1827.2008.02258.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

Review 1.  The endometrial lymphatic vasculature: function and dysfunction.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

Review 2.  [Metastatic mechanisms of uterine malignancies and therapeutic consequences].

Authors:  S F Lax; K F Tamussino; P F Lang
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

3.  Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer.

Authors:  Jane E Girling; Jacqueline F Donoghue; Fiona L Lederman; Leonie M Cann; Marc G Achen; Steven A Stacker; Peter Aw Rogers
Journal:  Reprod Biol Endocrinol       Date:  2010-07-08       Impact factor: 5.211

4.  Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.

Authors:  Elke E M Peters; Carla Bartosch; W Glenn McCluggage; Catherine Genestie; Sigurd F Lax; Remi Nout; Jan Oosting; Naveena Singh; Huub C S H Smit; Vincent T H B M Smit; Koen K Van de Vijver; Tjalling Bosse
Journal:  Histopathology       Date:  2019-06-10       Impact factor: 5.087

5.  The prognostic significance of tumor lymphangiogenesis and lymphatic vessel density in endometrioid carcinoma of the uterine corpus.

Authors:  Mika Sakaki; Masanori Yasuda; Mitsutake Yano; Yoshiya Goto; Masaru Nakamura; Hidekazu Kayano; Kosei Hasegawa
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.